55095-17-5

Usage

Uses

Used in Pharmaceutical Industry:
(4-bromophenyl)(phenyl)methylamine is used as a key intermediate in the synthesis of pharmaceuticals for its chemical structure and reactivity, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (4-bromophenyl)(phenyl)methylamine serves as a crucial component in the production of various agrochemicals, enhancing the effectiveness of these products in agricultural applications.
Used in Organic Material Synthesis:
(4-bromophenyl)(phenyl)methylamine is utilized as a building block in the synthesis of organic materials, leveraging its chemical properties to create materials with specific characteristics for use in different industries.

InChI:InChI=1/C13H12BrN/c14-12-8-6-11(7-9-12)13(15)10-4-2-1-3-5-10/h1-9,13H,15H2

Upstream product

• 1122-91-4 4-bromo-benzaldehyde 
• 55095-17-5 (4-bromophenyl)(phenyl)methanamine 
• 100-47-0 benzonitrile 
• 29097-44-7 (4-bromophenyl)(phenyl)methanimine 
• 1445534-56-4 C₁₄H₁₀BrNO 
• 127568-31-4 N-(4-bromo-benzhydryl)-formamide 
• 98-80-6 phenylboronic acid 
• 90-90-4 (4-bromophenyl)(phenyl)methanone 
• 7440-44-0 pyrographite 
• 118667-16-6 4-bromo-benzophenone-(E)-oxime 
• 99763-24-3 (Z)-4-bromobenzophenone oxime 

Downstream Products

• 55095-17-5 (+)-4-bromo-benzhydrylamine 
• 55095-17-5 (-)-4-bromo-benzhydrylamine 
• 117233-13-3 [(4-Bromo-phenyl)-phenyl-methyl]-urea 
• 1428526-27-5 4-((4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(methyl)phosphonic acid 
• 1428526-84-4 4-((tert-butoxycarbonylamino)(phenyl)methyl)phenylphosphinic acid 
• 1428526-85-5 tert-butyl N-((4-(ethoxyhydrophosphoryl)phenyl)(phenyl)methyl)carbamate 
• 1428526-86-6 tert-butyl N-{[4-(ethoxy(propyl)phosphoryl)phenyl](phenyl)methyl}carbamate 
• 1428526-87-7 ethyl 4-(amino(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-88-8 ethyl 4-((4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-89-9 ethyl 4-((4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-19-5 C₂₂H₃₀NO₅P 
• 1428526-21-9 diethyl 4-(amino(phenyl)methyl)phenylphosphonate 
• 1428526-23-1 diethyl 4-((4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenylphosphonate 
• 1428526-24-2 4-((4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl phosphonic acid 

Relevant academic research and scientific papers

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.

Hydrogen bond directed aerobic oxidation of amines via photoredox catalysis

An application of H-bonding interactions for directing the α-C-H oxidation of amines to amides and amino-ketones catalyzed by an organic photocatalyst is reported. The high efficiency of this method is demonstrated by the aerobic oxidation of pyrrolidines, diarylamines and benzylamines bearing urea groups with high yields and a wide substrate scope.

SUBSTITUTED PYRIMIDINES

The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

SUBSTITUTED PYRIMIDINES

Disclosed are substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

METHODS OF PREPARING SECONDARY CARBINAMINE COMPOUNDS WITH BORONIC ACIDS

The present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds of the formula Ia, formula Ib or formula IV from aldehydes of the formula II and boronic acids of the formula III or formula V, in the presence of ammonia or an ammonia equivalent of the formula NH4+X-.

METHODS OF PREPARING PRIMARY, SECONDARY AND TERTIARY CARBINAMINE COMPOUNDS IN THE PRESENCE OF AMMONIA

The present application relates to novel methods for the preparation of primary, secondary and tertiary carbinamine compounds, particularly the preparation of compounds of formulae I, IV and VI, from a carbonyl compound of formula II in the presence of ammonia or an ammonium equivalent of the formula NH4+X-, by way of allylation, crotylation, arylation, reductive amination and catalytic hydrogenation.

Pyrazolopyrimidines as therapeutic agents

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Substituted benzhydryl lactamimide derivatives

Novel compounds useful as diuretic agents and anticoagulants are represented by the following formula SPC1 Wherein m is a positive whole integer of from 1 to 3; n is a positive whole integer of from 3 to 7; R and R1 may be the same or different